These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 3259499)
21. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection. Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798 [TBL] [Abstract][Full Text] [Related]
22. [Effect of exogenous interleukin 2 on the functional activity of immunocompetent cells in mice with transplanted tumors]. Semenova-Kobzar' RA; Kushko LIa; Iudin VM; Koval'chuk EV; Berezhnaia NM Eksp Onkol; 1986; 8(2):39-42. PubMed ID: 2938929 [TBL] [Abstract][Full Text] [Related]
23. [Lymph node cell composition and DNA content in their different lymphocyte populations in mice with tumor induced by murine Moloney sarcoma virus]. Gudim-Levkovich KA; Iudin VM; Lysiuk LP; Kovbasiuk SA; Umanskiĭ IuA Biull Eksp Biol Med; 1979 Oct; 88(10):450-2. PubMed ID: 315243 [TBL] [Abstract][Full Text] [Related]
24. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver. Fuji N; Ueda Y; Fujiwara H; Toh T; Yoshimura T; Yamagishi H Clin Cancer Res; 2000 Aug; 6(8):3380-7. PubMed ID: 10955826 [TBL] [Abstract][Full Text] [Related]
25. Augmentation of in vitro interleukin 10 production after in vivo administration of interleukin 18 is activated macrophage-dependent and is probably not involved in the antitumor effects of interleukin 18. Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Ikegami H; Kurimoto M Anticancer Res; 1998; 18(6A):4267-74. PubMed ID: 9891477 [TBL] [Abstract][Full Text] [Related]
26. Interleukin 2 production by lymphoid cells from congenitally athymic (nu/nu) mice. MacDonald HR; Lees RK; Glasebrook AL; Sordat B J Immunol; 1982 Aug; 129(2):521-5. PubMed ID: 6123534 [TBL] [Abstract][Full Text] [Related]
27. Systemic administration of recombinant interleukin 2 stimulates in vivo lymphoid cell proliferation in tissues. Ettinghausen SE; Lipford EH; Mulé JJ; Rosenberg SA J Immunol; 1985 Aug; 135(2):1488-97. PubMed ID: 3891854 [TBL] [Abstract][Full Text] [Related]
28. Mast cells in regional lymph nodes responding to syngeneic and xenogeneic tumour MSVC and HeLa cell lines in BALB/c mice. Włodarski KH; Mazur S; Rychlik G Arch Immunol Ther Exp (Warsz); 1986; 34(1):1-5. PubMed ID: 3022665 [TBL] [Abstract][Full Text] [Related]
29. Morphologic studies of lymphoid tissues during the growth of an isotransplanted mouse tumor. Krüger G J Natl Cancer Inst; 1967 Jul; 39(1):1-15. PubMed ID: 6028286 [No Abstract] [Full Text] [Related]
30. Oral administration of Lactobacillus acidophilus induces IL-12 production in spleen cell culture of BALB/c mice bearing transplanted breast tumour. Yazdi MH; Soltan Dallal MM; Hassan ZM; Holakuyee M; Agha Amiri S; Abolhassani M; Mahdavi M Br J Nutr; 2010 Jul; 104(2):227-32. PubMed ID: 20193099 [TBL] [Abstract][Full Text] [Related]
31. Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis. Sheibanie AF; Khayrullina T; Safadi FF; Ganea D Arthritis Rheum; 2007 Aug; 56(8):2608-19. PubMed ID: 17665454 [TBL] [Abstract][Full Text] [Related]
32. Different migration patterns of antigen-presenting cells correlate with Th1/Th2-type responses in mice. Morikawa Y; Tohya K; Ishida H; Matsuura N; Kakudo K Immunology; 1995 Aug; 85(4):575-81. PubMed ID: 7558152 [TBL] [Abstract][Full Text] [Related]
33. Host genetics and resistance to acute Trypanosoma cruzi infection in mice: profiles and compartmentalization of IL-2-, -4-, -5-, -10-, and IFN-gamma-producing cells. Eksi S; Wassom DL; Powell MR J Parasitol; 1996 Feb; 82(1):59-65. PubMed ID: 8627502 [TBL] [Abstract][Full Text] [Related]
34. The effect of a 10-day space flight on the function, phenotype, and adhesion molecule expression of splenocytes and lymph node lymphocytes. Grove DS; Pishak SA; Mastro AM Exp Cell Res; 1995 Jul; 219(1):102-9. PubMed ID: 7543050 [TBL] [Abstract][Full Text] [Related]
35. Enhanced IL-10 and decreased IL-2 production after orthotopic corneal transplantation in mice. Hasková Z; Filipec M; Holán V Folia Biol (Praha); 1999; 45(1):21-5. PubMed ID: 10732714 [TBL] [Abstract][Full Text] [Related]
37. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state. Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900 [TBL] [Abstract][Full Text] [Related]
38. In vitro studies on the inhibitory effect of lymph-node cells. I. Antitumor activity of regional lymph-node cells from methylcholanthrene-induced sarcoma bearing mice on the same primary culture sarcoma cells. Osugi M Acta Med Okayama (1952); 1970 Aug; 24(4):447-56. PubMed ID: 4254199 [No Abstract] [Full Text] [Related]
39. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient. Doucet C; Meazza R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boye D; Ferrini S; Alileche A; Taoufik Y; Jasmin C; Azzarone B; Indiveri F Melanoma Res; 1997 Aug; 7 Suppl 2():S7-17. PubMed ID: 9578412 [TBL] [Abstract][Full Text] [Related]
40. Mechanisms of tolerance induction: splenocytes from total lymphoid irradiated mice inhibit the IL-2 pathway in TCR-activated CD4 cells. Field EH; Ye ZX; Rouse TM J Immunol; 1996 Nov; 157(9):3796-803. PubMed ID: 8892608 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]